(19)

(11)

EP 4 823 616 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24846776.3 (22) Date of filing: 13.12.2024

(51) International Patent Classification (IPC):  A61K 40/17(2025.01) A61K 40/31(2025.01) A61K 40/42(2025.01) C07K 14/705(2006.01) C12N 15/86(2006.01) A61K 40/30(2025.01) A61K 40/35(2025.01) C07K 14/725(2006.01) C07K 14/715(2006.01) (52) Cooperative Patent Classification (CPC): A61K 40/17; A61K 40/31; A61K 40/35; A61K 40/4211; A61K 40/30; A61K 2239/17; A61K 2239/22; A61K 2239/24; A61K 2239/31; C07K 14/7051; C07K 14/70528; C07K 14/70532; C07K 14/7155; C07K 2319/03; C07K 2319/33; C07K 2319/50; C07K 2319/70; C12N 15/86; C12N 2740/16043; C12N 2830/20 (86) International application number: PCT/US2024/060149 (87) International publication number: WO 2025/129084 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 13.12.2023 US 202363609821 P (71) Applicant: Umoja Biopharma, Inc. Seattle, Washington 98109 (US)	(72) Inventors: JARRELL, Dillon Seattle, WA 98109 (US) KONING, Ryan Seattle, WA 98109 (US) (74) Representative: J A Kemp LLP  80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)